How oxidation controls key protein switches in cells

Complexity of Protein Tyrosine Phosphatase Oxidation

NIH-funded research State University of New York at Albany · NIH-11324569

Researchers are looking at how small oxidation changes switch off protein regulators in cells, which could help people with diseases linked to oxidative stress.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionState University of New York at Albany NIH-funded
Lab location1 site (Albany, United States)
Project IDNIH-11324569 on NIH RePORTER

What this research studies

This lab project will map how protein tyrosine phosphatases (important regulators of cell signaling) are reversibly turned off by oxidation using biochemical tools and cellular models. The team will identify new oxidation and reduction mechanisms they recently discovered and test how these changes alter cell signaling and function. Work will include experiments in cultured cells and in vivo models to track oxidation states, manipulate specific proteins, and observe downstream effects. The aim is to find molecular targets that could guide future therapies for conditions driven by disrupted redox signaling.

Who could benefit from this research

Good fit: Although this is primarily lab-based and not enrolling patients now, people with conditions tied to oxidative stress or dysregulated cell signaling (for example certain cancers, neurodegenerative, or heart diseases) would be the kinds of patients who might benefit from future treatments arising from this work.

Not a fit: Patients with conditions that do not involve oxidative signaling pathways or where disease mechanisms are purely structural or non-redox related are unlikely to benefit directly from this project.

Why it matters

Potential benefit: If successful, this work could point to new ways to restore proper cell signaling and lead to therapies for diseases linked to oxidative stress, such as some cancers, neurodegenerative, and cardiovascular conditions.

How similar studies have performed: Previous research has shown that oxidation of protein tyrosine phosphatases affects cell signaling and disease, but the specific oxidation-relay mechanisms proposed here are recently described and remain to be validated.

Where this research is happening

Albany, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.